Special Issue "Potential Mechanism of Natural-Based Biomolecules for Disease Treatment"
Deadline for manuscript submissions: closed (22 May 2022) | Viewed by 7840
Interests: protease biochemistry; toxins; anti-cancer drug discovery; antibody therapy; venom-based peptides; prognostic and diagnostic biomarkers; proteomics
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomolecules: Novel Natural-based Biomolecules Discovery for Tackling Chronic Diseases
Special Issue in Biology: Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Special Issue in Molecules: Recent Advances in Natural Drug Discovery and Development – Is It a New Wave of Medicine?
Special Issue in Biology: Recent Prototype Drug Development: Insights in Protein Science and Enzymology for Precision Medicine
This Special Issue is the continuation of the previous Special Issue, "Novel Natural-based Biomolecules Discovery for Tackling Chronic Diseases" (https://www.mdpi.com/journal/biomolecules/special_issues/natural-based_biomolecules).
Natural-based biomolecules continuously play an important role in novel drug discovery for the treatment of various diseases. The development of natural peptide/protein-based, toxin-based, and antibody-based drugs can significantly improve the biomedical efficiency of disease-specific therapy.
This Special Issue explores the mechanisms and roles of signaling components in natural-based biomolecules, which have led to target therapy and immunotherapy for tackling diseases (e.g. cancer, diabetes, cardiovascular diseases, and rheumatoid arthritis), including but not limited to functional analysis of key genes, hormone contents, signal transduction networks, gene expression profiling, and post-translation modifications.
Prof. Dr. Hang Fai Kwok
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2100 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antibody therapy
- peptide/protein drug
- natural toxins
- targeted therapy
- combinatorial treatment
- mode of action